Skip to main content
Log in

Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination

  • Case Report
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Leptomeningeal dissemination of low-grade gliomas is an uncommon event. A 43-year old male presented with dizziness, gait ataxia, and diplopia. A nonenhancing lesion in the right cerebellar peduncle was identified, subtotally resected, and diagnosed as a grade II astrocytoma. After one year a nodular spread in the brain and leptomeninges was diagnosed, so the patient started chemotherapy with temozolomide and liposomal cytarabine. Complete remission was achieved after 12 months of treatment and the patient is still free from the disease after a follow-up of 24 months. We suggest that this combination may be a valuable treatment option.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Grier JT, Batchelor T (2006) Low-grade gliomas in adults. Oncologist 11:681–693

    Article  PubMed  Google Scholar 

  2. Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir (Wien) 126:84–92

    Article  CAS  Google Scholar 

  3. Pollack IF, Hurtt M, Pang D, Albright AL (1994) Dissemination of low grade intracranial astrocytomas in children. Cancer 73:2869–2878

    Article  CAS  PubMed  Google Scholar 

  4. D’Haene N, Coen N, Neugroschl C, Balériaux D, Salmon I (2009) Leptomeningeal dissemination of low-grade intramedullary gliomas: about one case and review. Clin Neurol Neurosurg 111:390–394

    Article  PubMed  Google Scholar 

  5. Hukin J, Siffert J, Velasquez L, Zagzag D, Allen J (2002) Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors. Neuro Oncol 4:253–260

    Article  PubMed  Google Scholar 

  6. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605–3613

    Article  PubMed  Google Scholar 

  7. Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–1721

    Article  CAS  PubMed  Google Scholar 

  8. Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J et al (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133–3138

    Article  CAS  PubMed  Google Scholar 

  9. Quinn JA, Reardon DA, Friedman AH, Rich JN, Sampson JH, Provenzale JM et al (2003) Phase II trial of temozolomide in patients with progressive low-grade glioma. J Clin Oncol 21:646–651

    Article  CAS  PubMed  Google Scholar 

  10. Ostermann S, Csajka C, Buclin T, Leyvraz S, Lejeune F, Decosterd LA (2004) Plasma and cerebrospinal fluid population pharmacokinetics of temozolomide in malignant glioma patients. Clin Cancer Res 10(11):3728–3736

    Article  CAS  PubMed  Google Scholar 

  11. Murry DJ, Blaney SM (2000) Clinical pharmacology of encapsulated sustained-release cytarabine. Ann Pharmacother 34:1173–1178

    Article  CAS  PubMed  Google Scholar 

  12. Chamberlain MC, Kormanik P, Howell SB, Kim S (1995) Pharmacokinetics of intralumbar DTC-101 for the treatment of leptomeningeal metastases. Arch Neurol 52:912–917

    CAS  PubMed  Google Scholar 

  13. Jaeckle KA, Batchelor T, O’Day SJ, Phuphanich S, New P, Lesser G et al (2002) An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis. J Neurooncol 57:231–239

    Article  PubMed  Google Scholar 

  14. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ et al (1999) A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5:3394–3402

    CAS  PubMed  Google Scholar 

  15. Lassaletta A, Perez-Olleros P, Scaglione C, Sirvent S, De Prada I, Perez-Martinez A et al (2007) Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child. J Neurooncol 83(3):303–306

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Grazia Passarin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Passarin, M.G., Moretto, G., Musso, A.M. et al. Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination. J Neurooncol 97, 439–444 (2010). https://doi.org/10.1007/s11060-009-0040-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-0040-0

Keywords

Navigation